<?xml version="1.0" encoding="UTF-8"?>
<ref id="b0360">
 <label>72</label>
 <element-citation publication-type="journal" id="h0360">
  <person-group person-group-type="author">
   <name>
    <surname>Pillaiyar</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Manickam</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Namasivayam</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Hayashi</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Jung</surname>
    <given-names>S.-H.</given-names>
   </name>
  </person-group>
  <article-title>An overview of severe acute respiratory syndrome-coronavirus (SARS-CoV) 3CL protease inhibitors: peptidomimetics and small molecule chemotherapy</article-title>
  <source>J Med Chem</source>
  <volume>59</volume>
  <issue>14</issue>
  <year>2016</year>
  <fpage>6595</fpage>
  <lpage>6628</lpage>
  <pub-id pub-id-type="doi">10.1021/acs.jmedchem.5b01461</pub-id>
  <pub-id pub-id-type="pmid">26878082</pub-id>
 </element-citation>
</ref>
